These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 31335153)
1. Improved Prediction of in Vivo Supersaturation and Precipitation of Poorly Soluble Weakly Basic Drugs Using a Biorelevant Bicarbonate Buffer in a Gastrointestinal Transfer Model. Jede C; Wagner C; Kubas H; Weigandt M; Weber C; Lecomte M; Badolo L; Koziolek M; Weitschies W Mol Pharm; 2019 Sep; 16(9):3938-3947. PubMed ID: 31335153 [TBL] [Abstract][Full Text] [Related]
2. Impact of amorphization and GI physiology on supersaturation and precipitation of poorly soluble weakly basic drugs using a small-scale in vitro transfer model. Auch C; Jede C; Harms M; Wagner C; Mäder K Int J Pharm; 2020 Jan; 574():118917. PubMed ID: 31811926 [TBL] [Abstract][Full Text] [Related]
3. Dissolution Kinetics of Nifedipine-Ionizable Polymer Amorphous Solid Dispersion: Comparison Between Bicarbonate and Phosphate Buffers. Sakamoto A; Sugano K Pharm Res; 2021 Dec; 38(12):2119-2127. PubMed ID: 34931285 [TBL] [Abstract][Full Text] [Related]
4. Application of an automated small-scale in vitro transfer model to predict in vivo precipitation inhibition. Jede C; Wagner C; Kubas H; Weber C; Weigandt M; Koziolek M; Weitschies W Int J Pharm; 2019 Jun; 565():458-471. PubMed ID: 31085255 [TBL] [Abstract][Full Text] [Related]
5. Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: The hidden role of bicarbonate buffer. Amaral Silva D; Al-Gousous J; Davies NM; Bou Chacra N; Webster GK; Lipka E; Amidon G; Löbenberg R Eur J Pharm Biopharm; 2019 Sep; 142():8-19. PubMed ID: 31195131 [TBL] [Abstract][Full Text] [Related]
6. The effect of buffer species on biorelevant dissolution and precipitation assays - Comparison of phosphate and bicarbonate buffer. Krollik K; Lehmann A; Wagner C; Kaidas J; Kubas H; Weitschies W Eur J Pharm Biopharm; 2022 Feb; 171():90-101. PubMed ID: 34592364 [TBL] [Abstract][Full Text] [Related]
7. The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS). Tsume Y; Matsui K; Searls AL; Takeuchi S; Amidon GE; Sun D; Amidon GL Eur J Pharm Sci; 2017 May; 102():126-139. PubMed ID: 28263914 [TBL] [Abstract][Full Text] [Related]
8. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability. Berlin M; Przyklenk KH; Richtberg A; Baumann W; Dressman JB Eur J Pharm Biopharm; 2014 Nov; 88(3):795-806. PubMed ID: 25195981 [TBL] [Abstract][Full Text] [Related]
9. Automated small-scale in vitro transfer model as screening tool for the prediction of in vivo-dissolution and precipitation of poorly solubles. Jede C; Wagner C; Kubas H; Weber C; Weigandt M; Koziolek M; Weitschies W Int J Pharm; 2019 Feb; 556():150-158. PubMed ID: 30553006 [TBL] [Abstract][Full Text] [Related]
10. Integration of Precipitation Kinetics From an In Vitro, Multicompartment Transfer System and Mechanistic Oral Absorption Modeling for Pharmacokinetic Prediction of Weakly Basic Drugs. Patel S; Zhu W; Xia B; Sharma N; Hermans A; Ehrick JD; Kesisoglou F; Pennington J J Pharm Sci; 2019 Jan; 108(1):574-583. PubMed ID: 30395833 [TBL] [Abstract][Full Text] [Related]
11. Dissolution Profiles of Immediate Release Products of Various Drugs in Biorelevant Bicarbonate Buffer: Comparison with Compendial Phosphate Buffer. Okamoto N; Higashino M; Yamamoto H; Sugano K Pharm Res; 2024 May; 41(5):959-966. PubMed ID: 38653942 [TBL] [Abstract][Full Text] [Related]
12. Is bicarbonate buffer suitable as a dissolution medium? Boni JE; Brickl RS; Dressman J J Pharm Pharmacol; 2007 Oct; 59(10):1375-82. PubMed ID: 17910812 [TBL] [Abstract][Full Text] [Related]
13. Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Dissolution of Ionizable and Nonionizable Drugs in a Compendial Dissolution Vessel. Salehi N; Al-Gousous J; Mudie DM; Amidon GL; Ziff RM; Amidon GE Mol Pharm; 2020 Oct; 17(10):3870-3884. PubMed ID: 32886520 [TBL] [Abstract][Full Text] [Related]
14. Drug Crystal Precipitation in Biorelevant Bicarbonate Buffer: A Well-Controlled Comparative Study with Phosphate Buffer. Yamamoto H; Sugano K Mol Pharm; 2024 Jun; 21(6):2854-2864. PubMed ID: 38718215 [TBL] [Abstract][Full Text] [Related]
15. In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs. Higashino H; Hasegawa T; Yamamoto M; Matsui R; Masaoka Y; Kataoka M; Sakuma S; Yamashita S Mol Pharm; 2014 Mar; 11(3):746-54. PubMed ID: 24460473 [TBL] [Abstract][Full Text] [Related]
16. Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers. Sheng JJ; McNamara DP; Amidon GL Mol Pharm; 2009; 6(1):29-39. PubMed ID: 19183104 [TBL] [Abstract][Full Text] [Related]
17. Prediction of Ketoconazole absorption using an updated in vitro transfer model coupled to physiologically based pharmacokinetic modelling. Ruff A; Fiolka T; Kostewicz ES Eur J Pharm Sci; 2017 Mar; 100():42-55. PubMed ID: 28011125 [TBL] [Abstract][Full Text] [Related]
18. A differential equation based modelling approach to predict supersaturation and in vivo absorption from in vitro dissolution-absorption system (idas2) data. Li J; Spivey N; Silchenko S; Gonzalez-Alvarez I; Bermejo M; Hidalgo IJ Eur J Pharm Biopharm; 2021 Aug; 165():1-12. PubMed ID: 33971275 [TBL] [Abstract][Full Text] [Related]
19. Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products. Liu F; Merchant HA; Kulkarni RP; Alkademi M; Basit AW Eur J Pharm Biopharm; 2011 May; 78(1):151-7. PubMed ID: 21255647 [TBL] [Abstract][Full Text] [Related]
20. In-line derivative spectroscopy as a promising application to a small-scale in vitro transfer model in biorelevant supersaturation and precipitation testing. Jede C; Wagner C; Kubas H; Weber C; Weitschies W J Pharm Pharmacol; 2018 Oct; 70(10):1315-1323. PubMed ID: 30062721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]